The evaluation is a multi-centre study using a mixed-methods approach across four work packages (WP).
This work package involves conducting observations and interviews with clinicians, patients and relatives and the review of patient clinical records to understand the decision making behind ReSPECT. This will take place across six NHS Acute Hospitals in England who are early adopters of the ReSPECT process.
This work package involves analysing National Cardiac Arrest Audit (NCAA) data to quantify the impact of ReSPECT on the frequency and outcomes from in-hospital resuscitation. This will take place on a national scale across 180 NHS Hospitals in the UK and will provide a comparison between hospitals that adopt ReSPECT and those that use other systems like DNACPR or other emergency care plans.
This work package involves reviewing patient clinical records and NHS safety thermometer data to assess the impact of ReSPECT on patient care. This will take place across the same six NHS Acute Hospitals in England used in WP1.
This work package involves carrying out focus groups with Primary Care Practitioners to establish uptake and attitudes to ReSPECT in the communities served by the acute hospitals taking part in WP1 & 3. We will collect data from sites and from regular meeting between sites, researchers and the ReSPECT National Working Group, responsible for developing the process to describe the context for implementation. We will synthesise the findings from all work packages to make recommendations for clinical practice future development of the ReSPECT process.
The study protocol can be downloaded here: ReSPECT protocol v5.0
The University of Warwick and University Hospitals Birmingham NHS Foundation Trust are the sponsors for this study based in the United Kingdom. We will be using information from participants in order to undertake this study and the University of Warwick will act as the data controller for this study. This means that we are responsible for looking after participants’ information and using it properly.
When will data collection start?
Data collection commenced in July 2017.
This study (IRAS ID: 204688) has received approval from the Health Research Authority, Coventry and Warwickshire Research Ethics Committee (17/WM/0134) and the Confidentiality Advisory Group (17/CAG/0060).
For general enquiries, please contact
Claire Jacques (Trial Manager)